FDA Inspection
Gilead Sciences, Inc.Gilead Sciences, Inc. – FDA Inspection, Jul 17, 2018
Record Details
This FDA Inspection record concerns Gilead Sciences, Inc., with an inspection on July 17, 2018, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · a7c9d301-177d-4aa7-accc-64106381e6fa
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1065316
- FDA center
- Human Drugs
- Project area
- Postmarket Surv. and Epidemiology
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 314.80(c)(1)(i)Late submission of 15-day report
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Gilead Sciences, Inc.
16| Date | Classification | Office | Project area |
|---|---|---|---|
| January 16, 2026 | NAI | Bioresearch Monitoring | |
| January 29, 2025 | Not classified | San Francisco District Office | |
| January 22, 2024 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| August 18, 2020 | NAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
| July 22, 2020 | VAI | Center for Drug Evaluation and Research | Bioresearch Monitoring |
Other documents for Gilead Sciences, Inc.
- FDA Inspection 1300496 - 2026-01-16
- FDA Inspection 1258330 - 2025-01-29
- FDA Inspection 1227801 - 2024-01-22
- FDA Inspection 1128174 - 2020-08-18
- FDA Inspection 1125580 - 2020-07-22
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.